Targeting plasma cells: Are we any closer to a panacea for diseases of antibody-secreting cells?

Research output: Contribution to journalReview ArticleResearchpeer-review

3 Citations (Scopus)

Abstract

Antibody-secreting cells (ASCs) are critical for a functional and effective adaptive immune system. In a number of illnesses, however, these same cells contribute to the underlying disease state leading to significant morbidity and mortality. While therapeutic targeting of antibody-secreting cells has progressed significantly over the last two decades, many of these conditions remain major health problems. In this review, we will discuss current and potential therapeutic targeting of ASCs in the context of the known biology of these cells.

Original languageEnglish
Pages (from-to)78-94
Number of pages17
JournalImmunological Reviews
Volume270
Issue number1
DOIs
Publication statusPublished - 1 Mar 2016

Keywords

  • Antibody-secreting cells
  • Plasma cells
  • Therapeutics

Cite this

@article{5bb7e650699e4e148848b69b176e25ee,
title = "Targeting plasma cells: Are we any closer to a panacea for diseases of antibody-secreting cells?",
abstract = "Antibody-secreting cells (ASCs) are critical for a functional and effective adaptive immune system. In a number of illnesses, however, these same cells contribute to the underlying disease state leading to significant morbidity and mortality. While therapeutic targeting of antibody-secreting cells has progressed significantly over the last two decades, many of these conditions remain major health problems. In this review, we will discuss current and potential therapeutic targeting of ASCs in the context of the known biology of these cells.",
keywords = "Antibody-secreting cells, Plasma cells, Therapeutics",
author = "Michael Low and Simona Infantino and George Grigoriadis and David Tarlinton",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/imr.12388",
language = "English",
volume = "270",
pages = "78--94",
journal = "Immunological Reviews",
issn = "0105-2896",
publisher = "Wiley-Blackwell",
number = "1",

}

Targeting plasma cells : Are we any closer to a panacea for diseases of antibody-secreting cells? / Low, Michael; Infantino, Simona; Grigoriadis, George; Tarlinton, David.

In: Immunological Reviews, Vol. 270, No. 1, 01.03.2016, p. 78-94.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Targeting plasma cells

T2 - Are we any closer to a panacea for diseases of antibody-secreting cells?

AU - Low, Michael

AU - Infantino, Simona

AU - Grigoriadis, George

AU - Tarlinton, David

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Antibody-secreting cells (ASCs) are critical for a functional and effective adaptive immune system. In a number of illnesses, however, these same cells contribute to the underlying disease state leading to significant morbidity and mortality. While therapeutic targeting of antibody-secreting cells has progressed significantly over the last two decades, many of these conditions remain major health problems. In this review, we will discuss current and potential therapeutic targeting of ASCs in the context of the known biology of these cells.

AB - Antibody-secreting cells (ASCs) are critical for a functional and effective adaptive immune system. In a number of illnesses, however, these same cells contribute to the underlying disease state leading to significant morbidity and mortality. While therapeutic targeting of antibody-secreting cells has progressed significantly over the last two decades, many of these conditions remain major health problems. In this review, we will discuss current and potential therapeutic targeting of ASCs in the context of the known biology of these cells.

KW - Antibody-secreting cells

KW - Plasma cells

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=84957692787&partnerID=8YFLogxK

U2 - 10.1111/imr.12388

DO - 10.1111/imr.12388

M3 - Review Article

AN - SCOPUS:84957692787

VL - 270

SP - 78

EP - 94

JO - Immunological Reviews

JF - Immunological Reviews

SN - 0105-2896

IS - 1

ER -